Inflammatory Markers in Patients With Active Migraine Headaches
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
The purpose of this study is to determine whether C-Reactive Protein (CRP) is elevated in patients with active migraine headaches. Secondary goal is to determine whether other inflammatory markers, such as Calcitonin Gene Peptide (CGRP), Vasoactive Intestinal Polypeptide (VIP) or Substance P (SP) are elevated in patients having a migraine headache.
Condition or disease
A random selection of patients both male and female from a primary care practice with a diagnosis of having migraine headaches will be enrolled. Thirty (30) patients will be recruited mainly from the primary care practice. Recruitment will include males and females aged 21-65. The patients who meet the inclusion criteria will be enrolled. The patients who do not have migraine headaches will also be enrolled and function as controls. Non-migraine patients will meet inclusion criteria 1, 2 and 3 and all of the exclusion criteria.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
21 Years to 65 Years (Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Subjects must sign a written informed consent.
Enrollment population would include males and females 21 years of age to 65 years of age.
Non-migraine subjects will be allowed in the control group
Have episodic migraine headaches
Patients to satisfy the diagnosis of migraine headaches with aura, without aura or mixed.
Must be able to differentiate migraine headaches from other headaches
Any medical condition in the opinion of the investigator that would make the subject unsuitable for enrollment.
Basilar or hemiplegic migraine headaches.
Pregnant woman or a nursing mother
History (within 1 year) or current evidence of drug or alcohol abuse.
More than 15 migraine headaches per month
Chronic daily headaches
Chronic use of NSAIDs
Current participation in a research study or within the last 30 days.